Alemtuzumab plus CHOP versus CHOP in elderly patients with peripheral T-cell lymphoma: the DSHNHL2006-1B/ACT-2 trial
2020 | journal article. A publication with affiliation to the University of Göttingen.
Jump to: Cite & Linked | Documents & Media | Details | Version history
Cite this publication
Alemtuzumab plus CHOP versus CHOP in elderly patients with peripheral T-cell lymphoma: the DSHNHL2006-1B/ACT-2 trial
Wulf, G. G. ; Altmann, B.; Ziepert, M.; D’Amore, F.; Held, G.; Greil, R. & Tournilhac, O. et al. (2020)
Leukemia,. DOI: https://doi.org/10.1038/s41375-020-0838-5
Documents & Media
Details
- Authors
- Wulf, Gerald G. ; Altmann, Bettina; Ziepert, Marita; D’Amore, Francesco; Held, Gerhard; Greil, Richard; Tournilhac, Olivier; Relander, Thomas; Viardot, Andreas; Wilhelm, Martin; Wilhelm, Christian; Pezzutto, Antonio; Zijlstra, Josee M.; Neste, Eric Van Den; Lugtenburg, Pieternella J.; Doorduijn, Jeanette K.; Gelder, Michel van; van Imhoff, Gustaaf W.; Zettl, Florian; Braulke, Friederike ; Nickelsen, Maike; Glass, Bertram; Rosenwald, Andreas; Gaulard, Philippe; Loeffler, Markus; Pfreundschuh, Michael; Schmitz, Norbert; Trümper, Lorenz
- Issue Date
- 2020
- Journal
- Leukemia
- ISSN
- 0887-6924
- eISSN
- 1476-5551
- Language
- English
